Cytokine Alteration In Multiple Myeloma (MM) Patients and Bisphosphonate (BP)-Related Osteonecrosis Of The Jaw (BRONJ)

被引：1
|
作者：
Badros, Ashraf
Philip, Sunita
Lesho, Patricia
Sadowska, Mariola
Weikel, Dianna
Meiller, Timothy
Lapidus, Rena
Hester, Lisa
Milliron, Todd
Goloubeva, Olga
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.3153.3153
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3153
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Bisphosphonate related osteonecrosis of the jaw
    Cuervo Pinna, Miguel Angel
    MEDICINA CLINICA, 2013, 141 (03): : 133 - 133
  • [32] Bioinformatics analyses of differentially expressed genes associated with bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma
    Sun, Jingnan
    Wen, Xue
    Jin, Fengyan
    Li, Yuying
    Hu, Jifan
    Sun, Yunpeng
    ONCOTARGETS AND THERAPY, 2015, 8 : 2681 - 2688
  • [33] Efficacy of laser therapy in the management of bisphosphonate-related osteonecrosis of the jaw (BRONJ): a systematic review
    João Batista Blessmann Weber
    Renata Stifelman Camilotti
    Monique Estér Ponte
    Lasers in Medical Science, 2016, 31 : 1261 - 1272
  • [34] Bisphosphonate-related osteonecrosis of the jaw (BRONJ): run dental management designs and issues in diagnosis
    Campisi, G.
    Di Fede, O.
    Musciotto, A.
    Lo Casto, A.
    Lo Muzio, L.
    Fulfaro, F.
    Badalamenti, G.
    Russo, A.
    Gebbia, N.
    ANNALS OF ONCOLOGY, 2007, 18 : 168 - 172
  • [35] Bisphosphonate-related osteonecrosis of jaw (BRONJ): an anti-angiogenic side-effect?
    Eugen B Petcu
    Saso Ivanovski
    Robert G Wright
    Mark Slevin
    Rodica I Miroiu
    Klara Brinzaniuc
    Diagnostic Pathology, 7
  • [36] EPIDEMIOLOGY OF BISPHOSPHONATE USE AND JAW OSTEONECROSIS INCIDENCE IN MULTIPLE MYELOMA PATIENTS IN THE REPUBLIC OF IRELAND
    McHugh, J.
    Kumar, R. S.
    O'Dalaigh, A.
    Breen, K.
    McCloy, M.
    Rajpal, R.
    Burke, A.
    Kelly, M.
    Desmond, R.
    O'Rafferty, C.
    Hayden, P.
    Leahy, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 388 - 388
  • [37] A brief review: characteristics of bisphosphonate-related osteonecrosis of the jaw (BRONJ) from the viewpoint of pathology
    Toyosawa, Satoru
    Murakami, Shumei
    Kishino, Mitsunobu
    Sato, Sunao
    Kogo, Mikihiko
    ORAL RADIOLOGY, 2013, 29 (02) : 105 - 110
  • [38] Bisphosphonate-related osteonecrosis of jaw (BRONJ): an anti-angiogenic side-effect?
    Petcu, Eugen B.
    Ivanovski, Saso
    Wright, Robert G.
    Slevin, Mark
    Miroiu, Rodica I.
    Brinzaniuc, Klara
    DIAGNOSTIC PATHOLOGY, 2012, 7
  • [39] Thrombospodin-1 Inhibition of Neovascularization in the Retina and Jaw as a Contributing Factor in Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ)
    McAllister, Bennett
    Harris, Tiffenie
    Borke, James
    Kang, Shirley
    Nakasato, Sonoco
    Elo, Jeffrey
    Fulzele, Sadanand
    Guerra, Carlos
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [40] Bioinformatic Data Mining for Candidate Drugs Affecting Risk of Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) in Cancer Patients
    Zhuang, Jinpeng
    Zu, Jianing
    Zhou, Changlong
    Sun, Yi
    Kong, Pengyu
    Jing, Yongbin
    DISEASE MARKERS, 2022, 2022
12345